Exane BNP Paribas analyst Rob Jones downgraded Gecina to Neutral from Outperform with a EUR 120 price target. The analyst made rating changes in the European real estate sector as part of the firm’s 2024 outlook.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on GECFF:
- Gecina price target raised to EUR 101 from EUR 97 at Jefferies
- Gecina downgraded to Underweight from Equal Weight at Morgan Stanley
- Gecina downgraded to Neutral from Buy at Goldman Sachs
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue